 | • レポートコード：QYR2104Z3495 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、パイプライン薬）、用途別市場規模（病院、研究所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・肺がん治療薬の種類別市場規模（化学療法、標的療法、パイプライン薬） ・肺がん治療薬の用途別市場規模（病院、研究所、診断センター、その他） ・肺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・肺がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、AstraZeneca、Eli Lilly and Company、Sanofi-Aventis、Pfizer、GlaxoSmithKline） ・結論 |
Lung Cancer Treatment Drugs are durgs used to cure lung cancer.
In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing lung cancer are driving the growth of the global lung cancer market.
Market Analysis and Insights: Global Lung Cancer Treatment Drugs Market
The global Lung Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Treatment Drugs market.
Global Lung Cancer Treatment Drugs Scope and Market Size
Lung Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Targeted Therapies
Pipeline Drugs
Segment by Application
Hospitals
Research Institutes
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
AstraZeneca
Eli Lilly and Company
Sanofi-Aventis
Pfizer
GlaxoSmithKline
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapies
1.2.4 Pipeline Drugs
1.3 Market by Application
1.3.1 Global Lung Cancer Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Treatment Drugs Market Perspective (2016-2027)
2.2 Lung Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Lung Cancer Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Treatment Drugs Industry Dynamic
2.3.1 Lung Cancer Treatment Drugs Market Trends
2.3.2 Lung Cancer Treatment Drugs Market Drivers
2.3.3 Lung Cancer Treatment Drugs Market Challenges
2.3.4 Lung Cancer Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Lung Cancer Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Treatment Drugs Revenue
3.4 Global Lung Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Lung Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Treatment Drugs Revenue in 2020
3.5 Lung Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Lung Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Lung Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Lung Cancer Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Lung Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Lung Cancer Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lung Cancer Treatment Drugs Market Size (2016-2027)
6.2 North America Lung Cancer Treatment Drugs Market Size by Type
6.2.1 North America Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Lung Cancer Treatment Drugs Market Size by Application
6.3.1 North America Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Lung Cancer Treatment Drugs Market Size by Country
6.4.1 North America Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Lung Cancer Treatment Drugs Market Size (2016-2027)
7.2 Europe Lung Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lung Cancer Treatment Drugs Market Size (2016-2027)
9.2 Latin America Lung Cancer Treatment Drugs Market Size by Type
9.2.1 Latin America Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Treatment Drugs Market Size by Application
9.3.1 Latin America Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Treatment Drugs Market Size by Country
9.4.1 Latin America Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lung Cancer Treatment Drugs Introduction
11.1.4 Roche Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Cancer Treatment Drugs Introduction
11.2.4 AstraZeneca Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Lung Cancer Treatment Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Lung Cancer Treatment Drugs Introduction
11.4.4 Sanofi-Aventis Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Lung Cancer Treatment Drugs Introduction
11.5.4 Pfizer Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Lung Cancer Treatment Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lung Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapies
Table 4. Key Players of Pipeline Drugs
Table 5. Global Lung Cancer Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lung Cancer Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lung Cancer Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Lung Cancer Treatment Drugs Market Share by Regions (2016-2021)
Table 9. Global Lung Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Lung Cancer Treatment Drugs Market Share by Regions (2022-2027)
Table 11. Lung Cancer Treatment Drugs Market Trends
Table 12. Lung Cancer Treatment Drugs Market Drivers
Table 13. Lung Cancer Treatment Drugs Market Challenges
Table 14. Lung Cancer Treatment Drugs Market Restraints
Table 15. Global Lung Cancer Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Lung Cancer Treatment Drugs Market Share by Players (2016-2021)
Table 17. Global Top Lung Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Treatment Drugs as of 2020)
Table 18. Ranking of Global Top Lung Cancer Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Lung Cancer Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lung Cancer Treatment Drugs Product Solution and Service
Table 22. Date of Enter into Lung Cancer Treatment Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Lung Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Lung Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Lung Cancer Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Lung Cancer Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Lung Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Lung Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Lung Cancer Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Lung Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Lung Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Lung Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Lung Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Lung Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Lung Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Lung Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Lung Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Lung Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Lung Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Lung Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Lung Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Lung Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Lung Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Lung Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Lung Cancer Treatment Drugs Product
Table 65. Roche Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Lung Cancer Treatment Drugs Product
Table 70. AstraZeneca Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Lung Cancer Treatment Drugs Product
Table 75. Eli Lilly and Company Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Sanofi-Aventis Company Details
Table 78. Sanofi-Aventis Business Overview
Table 79. Sanofi-Aventis Lung Cancer Treatment Drugs Product
Table 80. Sanofi-Aventis Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 81. Sanofi-Aventis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Lung Cancer Treatment Drugs Product
Table 85. Pfizer Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Lung Cancer Treatment Drugs Product
Table 90. GlaxoSmithKline Revenue in Lung Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapies Features
Figure 4. Pipeline Drugs Features
Figure 5. Global Lung Cancer Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Lung Cancer Treatment Drugs Report Years Considered
Figure 11. Global Lung Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Cancer Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Cancer Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Cancer Treatment Drugs Market Share by Regions (2022-2027)
Figure 15. Global Lung Cancer Treatment Drugs Market Share by Players in 2020
Figure 16. Global Top Lung Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Treatment Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Treatment Drugs Revenue in 2020
Figure 18. Global Lung Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Cancer Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 22. North America Lung Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 23. North America Lung Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 24. United States Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 28. Europe Lung Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 29. Europe Lung Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 30. Germany Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Treatment Drugs Market Share by Region (2016-2027)
Figure 40. China Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Lung Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Lung Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 62. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Treatment Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Non-small Cell Lung Cancer Market The global Drugs for Non-small Cell Lung Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の肺がん市場規模・現状・予測（2021年-2027年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…